251 related articles for article (PubMed ID: 29924913)
21. Antitumor effect of miR-27b-3p on lung cancer cells via targeting Fzd7.
Sun Y; Xu T; Cao YW; Ding XQ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4113-4123. PubMed ID: 29028088
[TBL] [Abstract][Full Text] [Related]
22. Ginsenoside-Rb1 promotes adipogenesis through regulation of PPARĪ³ and microRNA-27b.
Chan LS; Yue PY; Kok TW; Keung MH; Mak NK; Wong RN
Horm Metab Res; 2012 Oct; 44(11):819-24. PubMed ID: 22893262
[TBL] [Abstract][Full Text] [Related]
23. Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1).
Yan X; Zhao J; Zhang R
Cancer Chemother Pharmacol; 2017 Aug; 80(2):395-403. PubMed ID: 28667355
[TBL] [Abstract][Full Text] [Related]
24. miR-199a-5p is involved in doxorubicin resistance of non-small cell lung cancer (NSCLC) cells.
Jin Y; Wang H; Zhu Y; Feng H; Wang G; Wang S
Eur J Pharmacol; 2020 Jul; 878():173105. PubMed ID: 32278855
[TBL] [Abstract][Full Text] [Related]
25. MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer.
Lai J; Yang H; Zhu Y; Ruan M; Huang Y; Zhang Q
BMC Cancer; 2019 Jun; 19(1):602. PubMed ID: 31215481
[TBL] [Abstract][Full Text] [Related]
26. MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1.
Zhang W; Ji W; Zhao X
BMC Cancer; 2019 Nov; 19(1):1093. PubMed ID: 31718618
[TBL] [Abstract][Full Text] [Related]
27. Combination of SL327 and Sunitinib Malate leads to an additive anti-cancer effect in doxorubicin resistant thyroid carcinoma cells.
Wang W; Zhou J; Zhao L; Chen S
Biomed Pharmacother; 2017 Apr; 88():985-990. PubMed ID: 28178630
[TBL] [Abstract][Full Text] [Related]
28. Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2.
Carina V; Zito G; Pizzolanti G; Richiusa P; Criscimanna A; Rodolico V; Tomasello L; Pitrone M; Arancio W; Giordano C
Thyroid; 2013 Jul; 23(7):829-37. PubMed ID: 23301671
[TBL] [Abstract][Full Text] [Related]
29. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a.
Pacifico F; Crescenzi E; Mellone S; Iannetti A; Porrino N; Liguoro D; Moscato F; Grieco M; Formisano S; Leonardi A
J Clin Endocrinol Metab; 2010 Mar; 95(3):1421-30. PubMed ID: 20061417
[TBL] [Abstract][Full Text] [Related]
30. Effects of nutraceuticals on anaplastic thyroid cancer cells.
Allegri L; Rosignolo F; Mio C; Filetti S; Baldan F; Damante G
J Cancer Res Clin Oncol; 2018 Feb; 144(2):285-294. PubMed ID: 29197967
[TBL] [Abstract][Full Text] [Related]
31. MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism.
Pan C; Wang X; Shi K; Zheng Y; Li J; Chen Y; Jin L; Pan Z
PLoS One; 2016; 11(5):e0152090. PubMed ID: 27138141
[TBL] [Abstract][Full Text] [Related]
32.
Xu J; Lv S; Hou Y; Xu K; Sun D; Zheng Y; Zhang Z; Li X; Li Y; Chi G
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29187585
[TBL] [Abstract][Full Text] [Related]
33. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4.
Feng X; Zhao L; Gao S; Song X; Dong W; Zhao Y; Zhou H; Cheng L; Miao X; Jia L
Gene; 2016 Mar; 578(2):232-41. PubMed ID: 26701615
[TBL] [Abstract][Full Text] [Related]
34. Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogramming.
Ma L; Cheng Q
Biochem Biophys Res Commun; 2018 Apr; 498(4):912-917. PubMed ID: 29534964
[TBL] [Abstract][Full Text] [Related]
35. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma.
Matuszcak C; Lindner K; Eichelmann AK; Hussey DJ; Haier J; Hummel R
Surg Oncol; 2018 Sep; 27(3):392-401. PubMed ID: 30217293
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1.
Zhao X; Jin Y; Li L; Xu L; Tang Z; Qi Y; Yin L; Peng J
Pharmacol Res; 2019 Aug; 146():104276. PubMed ID: 31112750
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.
Chaudhari U; Nemade H; Gaspar JA; Hescheler J; Hengstler JG; Sachinidis A
Arch Toxicol; 2016 Dec; 90(12):3087-3098. PubMed ID: 26842497
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-27b-3p Promotes Tumor Progression and Metastasis by Inhibiting Peroxisome Proliferator-Activated Receptor Gamma in Triple-Negative Breast Cancer.
Shen SJ; Song Y; Ren XY; Xu YL; Zhou YD; Liang ZY; Sun Q
Front Oncol; 2020; 10():1371. PubMed ID: 32850439
[No Abstract] [Full Text] [Related]
39. Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARĪ³-dependent manner in leukemia cells.
Yousefi B; Azimi A; Majidinia M; Shafiei-Irannejad V; Badalzadeh R; Baradaran B; Zarghami N; Samadi N
Tumour Biol; 2017 Oct; 39(10):1010428317716501. PubMed ID: 28978268
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of the miR-325-3p/DPAGT1 axis supports HBV-positive HCC chemoresistance.
Li R; Xu T; Wang H; Wu N; Liu F; Jia X; Mi J; Lv J; Gao H
Biochem Biophys Res Commun; 2019 Nov; 519(2):358-365. PubMed ID: 31519321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]